14:46:42 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2025-02-02 Bokslutskommuniké 2024
2024-11-07 Kvartalsrapport 2024-Q3
2024-08-26 Kvartalsrapport 2024-Q2
2024-05-15 X-dag ordinarie utdelning CONTX 0.00 NOK
2024-05-14 Årsstämma 2024
2024-05-08 Kvartalsrapport 2024-Q1
2024-02-15 Bokslutskommuniké 2023
2023-11-02 X-dag halvårsutdelning CONTX 0.15741
2023-10-26 Kvartalsrapport 2023-Q3
2023-08-24 Kvartalsrapport 2023-Q2
2023-05-08 X-dag halvårsutdelning CONTX 0.15741
2023-05-03 Årsstämma 2023
2023-04-27 Kvartalsrapport 2023-Q1
2023-02-16 Bokslutskommuniké 2022
2022-10-20 Kvartalsrapport 2022-Q3
2022-08-11 Kvartalsrapport 2022-Q2
2022-05-05 X-dag ordinarie utdelning CONTX 0.00 NOK
2022-05-04 Årsstämma 2022
2022-04-21 Kvartalsrapport 2022-Q1
2022-02-17 Bokslutskommuniké 2021
2021-12-10 Extra Bolagsstämma 2021
2021-10-21 Kvartalsrapport 2021-Q3
2021-08-12 Kvartalsrapport 2021-Q2
2021-05-06 X-dag ordinarie utdelning CONTX 0.00 NOK
2021-05-05 Årsstämma 2021
2021-04-22 Kvartalsrapport 2021-Q1
2021-02-18 Bokslutskommuniké 2020
2020-10-22 Kvartalsrapport 2020-Q3
2020-08-19 Split CONTX 1:10
2020-08-13 Kvartalsrapport 2020-Q2
2020-08-05 Extra Bolagsstämma 2020
2020-05-07 X-dag ordinarie utdelning CONTX 0.00 NOK
2020-05-06 Årsstämma 2020
2020-04-23 Kvartalsrapport 2020-Q1
2020-02-20 Bokslutskommuniké 2019
2019-10-24 Kvartalsrapport 2019-Q3
2019-08-15 Kvartalsrapport 2019-Q2
2019-05-09 X-dag ordinarie utdelning CONTX 0.00 NOK
2019-05-08 Årsstämma 2019
2019-04-25 Kvartalsrapport 2019-Q1
2019-02-21 Bokslutskommuniké 2018
2018-10-25 Kvartalsrapport 2018-Q3
2018-08-16 Kvartalsrapport 2018-Q2
2018-05-11 X-dag ordinarie utdelning CONTX 0.00 NOK
2018-05-09 Årsstämma 2018
2018-04-26 Kvartalsrapport 2018-Q1
2018-02-22 Bokslutskommuniké 2017
2017-10-26 Kvartalsrapport 2017-Q3
2017-08-17 Kvartalsrapport 2017-Q2
2017-05-11 X-dag ordinarie utdelning CONTX 0.00 NOK
2017-05-10 Årsstämma 2017
2017-04-27 Kvartalsrapport 2017-Q1
2017-02-23 Bokslutskommuniké 2016
2016-10-27 Kvartalsrapport 2016-Q3
2016-08-18 Kvartalsrapport 2016-Q2
2016-04-21 Kvartalsrapport 2016-Q1
2016-04-21 X-dag ordinarie utdelning CONTX 0.00 NOK
2016-04-20 Årsstämma 2016
2016-02-18 Bokslutskommuniké 2015
2015-10-22 Kvartalsrapport 2015-Q3
2015-08-20 Kvartalsrapport 2015-Q2
2015-04-23 X-dag ordinarie utdelning CONTX 0.00 NOK
2015-04-23 Kvartalsrapport 2015-Q1
2015-04-22 Årsstämma 2015
2015-02-19 Bokslutskommuniké 2014
2014-10-23 Kvartalsrapport 2014-Q3
2014-08-21 Kvartalsrapport 2014-Q2
2014-05-12 15-7 2014
2014-04-24 X-dag ordinarie utdelning CONTX 0.00 NOK
2014-04-24 Kvartalsrapport 2014-Q1
2014-04-23 Årsstämma 2014
2014-02-20 Bokslutskommuniké 2013
2013-10-24 Kvartalsrapport 2013-Q3
2013-08-22 Kvartalsrapport 2013-Q2
2013-06-13 X-dag ordinarie utdelning CONTX 0.00 NOK
2013-06-12 Årsstämma 2013
2013-04-25 Kvartalsrapport 2013-Q1
2013-02-21 Bokslutskommuniké 2012
2012-10-25 Kvartalsrapport 2012-Q3
2012-08-23 Kvartalsrapport 2012-Q2
2012-06-14 X-dag ordinarie utdelning CONTX 0.00 NOK
2012-06-13 Årsstämma 2012
2012-04-26 Kvartalsrapport 2012-Q1
2012-02-23 Bokslutskommuniké 2011
2011-10-27 Kvartalsrapport 2011-Q3
2011-08-25 Kvartalsrapport 2011-Q2
2011-06-10 X-dag ordinarie utdelning CONTX 0.00 NOK
2011-06-09 Årsstämma 2011
2011-04-28 Kvartalsrapport 2011-Q1
2011-02-17 Bokslutskommuniké 2010
2010-10-21 Kvartalsrapport 2010-Q3
2010-08-19 Kvartalsrapport 2010-Q2
2010-06-04 X-dag ordinarie utdelning CONTX 0.00 NOK
2010-06-03 Årsstämma 2010
2010-04-21 Kvartalsrapport 2010-Q1
2010-02-18 Bokslutskommuniké 2009
2009-10-22 Kvartalsrapport 2009-Q3
2009-08-20 Kvartalsrapport 2009-Q2
2009-04-23 Kvartalsrapport 2009-Q1
2008-06-06 X-dag ordinarie utdelning CONTX 1.50 NOK

Beskrivning

LandSverige
ListaOB Match
SektorHälsovård
IndustriMedicinteknik
ContextVision är ett medicinteknologiskt bolag. Bolaget specialiserar sig inom bildanalys och artificiell intelligens. Bland bolagets produkter återfinns avancerade bildförbättringsprogram för ultraljud, MRI, röntgen och mammografi. Programvarorna används idag av sjukhus och forskningsinstitut på global nivå. Bolaget grundades 1983 och har sitt huvudkontor i Stockholm.
2024-05-14 15:30:00

ContextVision (publ), org. no. 556377-8900 (the "Company"), held its Annual General Meeting on May 14, 2024, at 13:00 at the company headquarters at Holländargatan 13, 113 36 Stockholm.  Major items approved by the Annual General Meeting include the below.

Adoption of the accounts

The Annual General Meeting approved the Company's income statement and balance sheet for 2023. The Board members and the Managing Director were discharged from liability for the fiscal year 2023.

Disposition of profits
The Annual General Meeting resolved, in accordance with the Board's proposal, that this year's results shall be carried forward.

  • The annual financial report regarding 2023 was approved by the AGM.
  • Disposition of financial results according to the proposal of the Board of Directors was approved.
Board and auditor fees
  • The Remuneration report for the Board of Directors and senior executives was approved.

  • Board compensation was decided according to the following:

  • The chairman of the board will be paid SEK 385.000 (previously 350.000) for the period until next AGM.
  • Other members of the board will be paid SEK 253.000 (previously 230.000 for a board member who is not also a main shareholders) for the period until next AGM.

  • The audit fee will be based on current account.

Board of Directors and auditor

It was approved that the number of board members should be 4, and the number of deputies should be 0.
  • Olof Sandén, Martin Hedlund, Sven Günther-Hanssen and Martin Ingvar were reelected as board members. Olof Sandén was re-elected as chairman of the board.
  • No deputy members were elected.

Grant Thornton was re-elected as auditor for the coming year, with acting auditor Joakim Söderin.

För ytterligare information, vänligen kontakta:

Richard Hallström, CFO
richard.hallstrom@contextvision.com

About ContextVision

ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. Our cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.